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Pseudomonas aeruginosa (PA) is an important airway pathogen of cystic fibrosis and
chronic obstructive disease patients. Multiply drug resistant PA is becoming increasing
prevalent and new strategies are needed to combat such insidious organisms. We have
previously shown that a mucoid, mucA22 mutant PA is exquisitely sensitive to acidified
nitrite (A-NO−, pH 6.5) at concentrations that are well tolerated in humans. Here, we2
used a transposon mutagenesis approach to identify PA mutants that are hypersensitive
to A-NO−. Among greater than 10,000 mutants screened, we focused on PA4455, in2
which the transposon was found to disrupt the production of a putative cytoplasmic
membrane-spanning ABC transporter permease. The PA4455 mutant was not only
highly sensitive to A-NO−, but also the membrane perturbing agent, EDTA and the2
antibiotics doxycycline, tigecycline, colistin, and chloramphenicol, respectively. Treatment
of bacteria with A-NO− plus EDTA, however, had the most dramatic and synergistic2
effect, with virtually all bacteria killed by 10mM A-NO−, and EDTA (1mM, aerobic,2
anaerobic). Most importantly, the PA4455mutant was also sensitive to A-NO− in biofilms.2
A-NO− sensitivity and an anaerobic growth defect was also noted in two mutants (rmlC2
andwbpM) that are defective in B-band LPS synthesis, potentially indicating amembrane
defect in the PA4455 mutant. Finally, this study describes a gene, PA4455, that when
mutated, allows for dramatic sensitivity to the potential therapeutic agent, A-NO− as2
well as EDTA. Furthermore, the synergy between the two compounds could offer future
benefits against antibiotic resistant PA strains.
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INTRODUCTION
A hallmark of two major airway diseases, chronic obstructive
pulmonary disease (COPD) and cystic fibrosis (CF), is infection
by the opportunistic Gram-negative, rod-shaped pathogen,
Pseudomonas aeruginosa (PA). COPD is characterized by airway
epithelial debridement, the primary cause of which is chronic
smoking (Hassett et al., 2014). In contrast, CF is an autosomal
recessive inherited disease resulting in mutations in the cystic
fibrosis transmembrane regulator gene (CFTR) on chromosome
7 that affects the function of many organs including but not
limited to the lung, liver, pancreas, intestine, skin, and testes
(Boucher, 2002). However, with time, it is airway infection in
CF that leads to pulmonary insufficiency and ultimately death
of the patient at an average age of ∼39 (MacKenzie et al., 2014).
Complicating both diseases are in vivo mutations that occur in
the mucA gene of PA, encoding an inner membrane spanning
anti-sigma factor (Martin et al., 1993; Valderrey et al., 2010).
The most common mutation, mucA22, is characterized by a
deletion of a G residue at base 430, resulting in a truncated
MucA protein of ∼15.8 kDa (Martin et al., 1993); wild-type
MucA is 21 kDa. Most notably, mucA mutations allow for the
sigma factor AlgT(U) (alternatively σE or σ22) to transcribe genes
involved in the regulation and production of a highly viscous
exopolysaccharide known as alginate. The production of alginate
allows for increased resistance to antibiotics (Hentzer et al.,
2001; Murphy et al., 2008), phagocytic killing (Meshulam et al.,
1984), and markedly decreases the overall pulmonary function
in both COPD and CF patients, especially during exacerbations
of both diseases (Govan and Deretic, 1996; Hassett et al., 2014).
Often, multiple antibiotic classes including aminoglycosides, β-
lactams, quinolones, macrolides, and polymyxins are used to
combat such refractory infections, yet during chronic infections,
frequent use of these antibiotics results in strains that develop
resistance. Therefore, novel treatment strategies are needed
to reduce or even completely eradicate such problematic
organisms.
In 2006, our group reported an important and novel
observation that slightly acidified nitrite (A-NO−2 ) at the pH
resembling that of the CF airway surface liquid (6.3–6.5; Coakley
et al., 2003; Yoon et al., 2006) killedmucoid PA in both planktonic
and biofilm culture, in sterile CF airway transplant sputum, and
the findings were also substantiated in a murine lung infection
model (Yoon et al., 2006). A-NO−2 displayed no adverse effects on
primary CF airway epithelia when used at levels 20-fold higher
(300mM) than that required to kill mucoid PA (Yoon et al.,
2006). Recent studies on PA biofilms grown on CF primary
epithelial cells showed that A-NO−2 killed PA biofilms, inhibited
the activity of aminoglycosides, yet demonstrated synergy with
colistomethate (Zemke et al., 2014, 2015). Toxicology studies
using dogs and rats revealed that inhalation of nebulized NaNO2
for 28 days was well tolerated in rats and dogs at doses up
to 19–20mg/kg: doses where the no observed adverse effect
level (NOAEL) was established (Major et al., 2010). In addition,
from a human use standpoint, NO−2 is already used as a
food preservative of red meats and a treatment for cyanide
poisoning.
In this study, we first used a transposon (Tn) mutant
approach to screen for PA mutants that demonstrate increased
susceptibility to A-NO−2 when compared to wild-type and a
mucoid mucA22 mutant. From a panel of ∼10,000 Tn mutants,
we focused on a very sensitive mutant that had a Tn insertion
in the PA4455 gene, encoding a putative cytoplasmic membrane-
spanning ABC transporter permease. ATP-binding cassette
transporters (or ABC transporters) are members of a protein
superfamily that are present throughout various phyla, ranging
from bacteria to humans (Higgins, 1992). These proteins utilize
ATP to import small molecules including nutrients, antibiotics,
drugs, and a myriad of other molecules. The PA4455 mutant
was extremely sensitive to A-NO−2 , EDTA and several antibiotics.
We also found that two mutants unable to generate the B-band
lipopolysaccharide/O-side chain, rmlC and wbpM, are defective
in anaerobic growth and demonstrate increased susceptibility to
both A-NO−2 and EDTA, and especially when the two reagents
were combined. From a translational perspective, a means to
target PA4455 with novel drugs could possibly enhance the
overall efficiency of killing problematic PA infections, especially
those associated with CF and COPD.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The bacteria and all primers designed and used for PCR
reactions used in this study are listed in Table 1. Organisms were
grown in either Luria-Bertani broth (LB), LB-100mM KNO3
(LBN) ± 50mM potassium phosphate, pH 6.5 or Pseudomonas
isolation agar (PIA). Aerobic cultures were grown at 37◦C with
shaking at 180 rpm at a 1/10 volume to total Erlenmeyer flask
volume. Anaerobic cultures were grown in a Coy laboratories
anaerobic chamber at 37◦C. Media were also solidified with
1.5% Bacto-agar. Frozen bacterial stocks were stored at −80◦C
in a 1:1 mixture of 30% glycerol and stationary-phase bacterial
suspension.
Manipulation of Recombinant DNA and
Genetic Techniques
All plasmid and chromosomal nucleic acid manipulations
were performed by standard techniques (Maniatis et al.,
1982). Plasmid DNA was transformed into E. coli strain
DH5α-MCR (Protein Express, Cincinnati, OH). To detect
the presence of insert DNA, X-Gal (5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside; 40µg/ml) was added to agar
media. Restriction endonucleases and T4 DNA ligase were
used as specified by the vendor (Invitrogen/Gibco-BRL Corp.,
Gaithersburg, MD). Plasmid DNA was isolated using the
QIAprep Spin Miniprep Kit (Qiagen) and restriction fragments
were recovered from low melting point agarose gels. PCRs for
genes of interest were performed by using Pfu DNA polymerase
(BRL) and appropriate primers in an MJ Research thermal
cycler, with 30 cycles of denaturation (2min, 94◦C), annealing
(1min, 54◦C), and extension (1min 30 s, 72◦C). Amplified DNA
fragments were gel purified, cloned into pCR2.1 (Invitrogen), and
sequenced.
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TABLE 1 | Bacterial strains, plasmids and oligonucleotides used in this study.
Strain, plasmid or oligonucleotide Description (relevant genotype or phenotype) or sequence (5′ to 3′) Source, reference, or RE site
E. coli
DH5α F− 880dlacZ1M15 endA1 recA1 hsdR17(r−
K
m−
K
) supE44 thi-1 gyrA96
1(lacZYA-argF)U169
Invitrogen
S17-1 λ pir Pro- Res- Mod+ recA; integrated RP4-Tet::Mu-Kan::Tn7, Mob+ Simon et al., 1983
P. aeruginosa
PAO1 Wild-type, prototroph Holloway et al., 1979
PAO11mucA PAO1 deletion mutant of mucA gene This study
PA4455::Tn-Gmr PAO1 transposon mutant This study
PA4455::Gm PAO11PA4455::Gm insertion mutant This study
rmlC PAO1 derivative, rmlC::Gm insertion, A−B− Rahim et al., 2000
rmd R1 05, R2 O5 PAO1 derivative, rmd::Gm insertion, A
−B+ Rocchetta et al., 1998a,b
wbpM PAO1 derivative, wbpM::Gm insertion, A+B− Creuzenet and Lam, 2001
PA4455::Gm (pUCP-PA4455) Complemented PA4455::Gm mutant by plasmid-borne pUCP-PA4455 This study
PAO1::attB::PA4455-lacZ Promoter of PA4455 and lacZ transcriptional fusion was integrated at the chromosomal attB
site of PAO1
This study
PLASMIDS
pUCGM Source for Gmr cassette, ApR, GmR Schweizer, 1993
pQF50 Broad-host-range transcriptional fusion vector with a promoterless lacZ, ApR Farinha and Helinski, 1990
mini-CTX1 Integration proficient plasmid for P. aeruginosa, TcR Hoang et al., 2000
pEX100T-KS Pseudomonas gene replacement suicide vector with modified multiple cloning site, sacB,
oriT, CbR
Schweizer and Hoang, 1995
pUCPPA4455 798 bp PA4455 gene cloned into EcoRI/BamHI sites of pUCP20, ApR This study
pHA531 nirS::lacZ transcriptional fusion in pQF50, ApR Arai et al., 1995
pHA532 nirQ::lacZ transcriptional fusion in pQF50, ApR Arai et al., 1995
pHA533 norC::lacZ transcriptional fusion in pQF50, ApR Arai et al., 1995
pQF50-narK narK promoter cloned into pQF50, ApR This study
mini-CTX1-PA4455-lacZ A 4-kb fragment containing promoter of PA4455 and lacZ fusion cloned into XhoI/HindIII
sites of the vector pmini-CTX1, TcR
This study
pEX1PA4455::Gm A 4-kb fragment containing flanking sequences of PA4455 and transposon insertion
cassette cloned into NotI/SpeI sites of pEX100T-KS, CbR, GmR
This study
pEX1OPABC::FRT-Gm A 3-kb fragment containing flanking sequences of the operon from PA4452 to PA4456 and
the FRT-GmR-FRT cassette cloned into EcoRI/BamHI sites of pEX100T-KS, CbR, GmR
This study
OLIGONUCLEOTIDES
AD2 5′-CANGCTWSGTNTSCAA Caetano-Anolles, 1993
GM447 5′-GTGCAAGCAGATTACGGTGACGAT Caetano-Anolles, 1993
GM464 5′-TGACGATCCCGCAGTGGCTCTC Caetano-Anolles, 1993
Pr4455/Xh5′ CCGCTCGAGCGAATGTGGCGCCTGGAT This study
Pr4455/Bm3′ CGGGATCCCATCAGGACTCCTTGCGATGC This study
PA4455/Eco5′ GGAATTCATGACTGGGAGAGCGCTGATGCGTAGAGTCTCTCCCCTC This study
PA4455/Bm3′ CGGGATCCTCAGAAATCTCCAAACATCAAAGC This study
qPCR OLIGONUCLEOTIDES
PA4452 FWD CCTGTTGCTGGCCTTCATA This study
PA4452 REV CTGCTGACCTTGGCAATCT This study
PA4453 FWD AACGCGCTGCTCGAATA This study
PA4453 REV CTGTCACGGATCTCCATGTT This study
PA4454 FWD GACCATGGAGATCAACCAGAAC This study
PA4454 REV GACGCTGATGCCGATGTATT This study
PA4455 FWD ATGAAGGCCACCGAACAG This study
PA4455 REV CAGCGGCATGGAGATGAA This study
PA4456 FWD TCACCGATCTCGACGTCTT This study
PA4456 REV GAAGCTTCATCAGGACGATGT This study
acpP FWD AGGAAGAAGAAGTCACCAACAG This study
acpP REV TCCTCTTCCAGAGCCATCA This study
ApR, ampicillin resistant; CbR, carbenicillin resistant; TcR, tetracycline resistant; GmR, gentamycin resistant.
Frontiers in Microbiology | www.frontiersin.org 3 April 2016 | Volume 7 | Article 291
McDaniel et al. ABC Transporter Supports A-NO−2 Resistance
Construction of PA Mutants
Transposon (Tn) Mutagenesis
Wild-type strain PAO1 was subjected to transposon mutagenesis
using the mariner transposon vector, pBT20 (Kulasekara et al.,
2005). The transposon within pBT20 was conjugally transferred
by biparental mating using E. coli S17-1 λ pir into strain
PAO1 following a protocol described elsewhere (Kulasekara
et al., 2005). Mating mixtures were scraped and resuspended in
1ml of L-broth. Suspensions (300µl) were spread evenly onto
Pseudomonas isolation agar (PIA) plates containing gentamicin
(Gm) at 150µg/ml, and incubated at 37◦C for 48 h. Conjugants
were picked and patched onto freshly prepared LBN plates,
pH 6.5 containing 15mM A-NO−2 and further incubated
again at 37◦C for 48 h. A-NO−2 sensitive conjugants were
selected, purified and confirmed for susceptibility to A-NO−2 .
Transposon insertion sites were determined through sequencing
the flanking region of the transposon by a semi-random
PCR method, as described previously (Caetano-Anolles, 1993)
using random primer AD2 and transposon-specific primer
Gm447, followed by the nested primers Gm464 and AD2
(Table 1).
Allelic Exchange, Sucrose Counter-Selection
The strategy for insertional inactivation of some of the
genes, primarily PA4455 derivatives listed in Table 1 was
facilitated by gene disruption with an 850-bp gentamicin
resistance (GmR) cassette from pUCGM (Schweizer, 1993).
The gene replacement vector pEX100T (Schweizer, 1992)
was used to allow for selection of double-crossover events
within putative recombinants cultured on LB-agar medium
containing 150µg/ml Gm and subsequently with 7% sucrose for
counterselection. All mutants were confirmed by PCR and DNA
sequencinxg analysis.
qPCR Analysis of Wild-Type and Mutant
Strains
Strains PAO1, PA4455, and PA4455 complemented with pUCP-
PA4455 were grown overnight in LB media. The strains were
then sub-cultured the next day into fresh LB and allowed
to grow to late log phase. The bacteria were then harvested
and subjected to RNA extraction using an RNeasy Protect
Bacteria Mini Kit (Qiagen), including a DNase reaction to
remove endogenous genomic DNA. Equal amounts of RNA were
used in a Reverse Transcriptase Reaction (Im-Prom II Reverse
Transcription System) to obtain total cDNA that was then used
in a PCR reaction to confirm qualitatively the absence of the gene
from the mutant strain. Subsequently, the same samples were
used in a qPCR reaction using the StepOnePlus System (Thermo
Scientific, Applied Biosystems). Amplification was detected
using PowerUp SYBR Green Master Mix (Applied Biosystems).
Primers directed against PA4452, PA4453, PA4454, PA4455,
PA4456 and a “housekeeping” gene, acpP, were developed using
IDT primer design tools (Integrated DNA Technologies) to
create ∼100-bp fragments, so as tominimize errors between gene
amplification measurements. Threshold cycle values were used
to determine relative gene expression using the 11CT method
(Livak and Schmittgen, 2001).
SDS, EDTA, and NaNO2 Killing Studies
Aerobically grown bacteria were serially diluted on square Petri
dishes containing either LB or LBN agar, pH 6.5, ± 7.5 or
17mM A-NO−2 , 0.5% SDS, or 1mM EDTA. Details of the strains
used for these studies are provided in the figure legends. The
diluted suspensions were spotted (10µl) on the surfaces of the
plates and the organisms allowed to incubate at 37◦C under
aerobic or anaerobic conditions, the latter using a Coy Laboratory
Anaerobic Chamber (Grass Lake, MI).
PPA4455–lacZ Fusion and Complementary
Plasmid Construction
The PPA4455 − lacZ transcriptional fusion was constructed by
amplifying the PA4455 operon promoter region, encompassing
nucleotides 810–1223 bp upstream of the start codon of
PA4455. PCR was performed using primers Pr4455/Xh5′ and
Pr4455/Bm3′ with PAO1 chromosomal DNA. The resulting 413-
bp fragment was excised with XhoI and BamHI, and ligated
to a 3-kb BamHI/HindIII-digested lacZ fragment. The resultant
fusion was then cloned between the XhoI and HindIII sites of
mini-CTX1 to yield mini-CTX1-PPA4455 − lacZ. Chromosomal
integration of this mini-CTX1-PPA4455 − lacZ fusion vector in
PA, excision of unwanted plasmid sequences and verification
of insertion at the chromosomal attB locus were performed
as described previously (Hoang et al., 2000). For genetic
complementation studies, the coding region of PA4455 was
amplified from PAO1 chromosomal DNA using oligonucleotides
PA4455/Eco5′ and PA4455/Bm3′. The EcoRI/BamHI-digested
PCR product was cloned into pUCP20 (Schweizer, 1991) that
had been digested with the same enzymes. Competent cells of the
PAO1 PA4455mutant were prepared and electroporated with 50
ng of the plasmid, pUC-PA4455. Transformants were selected on
PIA plates containing carbenicillin at 500µg/ml.
lacZ Transcriptional Analysis of
PPA4455-lacZ and pQF50 Derivative
Containing Strains
For PPA4455 − lacZ, overnight cultures of PAO1 attB::PPA4455 −
lacZ were diluted 1/100 into 50ml of fresh LBN pH 6.5 and grown
to early log phase, after which the samples were aliquoted into
test tubes containing the respective treatments. These were then
incubated for 2 h aerobically with shaking or 2.5 h anaerobically,
both at 37◦C. For pQF50 derivative strains, overnight aerobic
cultures of the bacteria were inoculated 1/100 into fresh LBN,
and the cultures were incubated aerobically or anaerobically
overnight. Analysis of the activation of lacZ was carried out
using methods described by Miller using slight modifications
(Miller, 1992; Su et al., 2014). Briefly, a 400-µl suspension of
bacteria (OD600∼1.0) was transferred to a glass tube and mixed
with 600µl of Z-buffer. Twenty µl of 0.1% SDS and 40µl
of chloroform were then added to the samples and vortexed.
The samples were then incubated in a 28◦C water bath for
5min, after which 200µl of an ortho-nitrophenyl-β-galactoside
solution (ONPG, 4mg/ml) was added to each sample. After
briefly vortexing a timer was started and the samples were
returned to the 28◦C water bath. Reactions were stopped by
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the addition of 500µl of a 1M sodium carbonate solution. The
samples were then centrifuged and 1ml of the supernatant was
analyzed spectrophotometrically at 420 nm. Utilizing the OD600,
reaction time, and A420, the Miller units of each sample were
then calculated. Results were analyzed using SPSS software (IBM,
version 23). For pQF50 variants, independent T-tests were used
to determine significance between PAO1 and PA4455 for each
plasmid. For PPA4455− lacZ assays, one-way ANOVAwas utilized
to determine the significant differences among the group.
Confocal Laser Scanning Microscopic
Analysis for Determination of A-NO−2
Sensitivity of PA Biofilms
Biofilms were grown in glass-bottomed culture dishes (MatTek,
Ashland, MA) essentially as described by Yoon et al. (2002).
Briefly, overnight cultures were grown in L-broth to stationary
phase and diluted 1:100 into the culture dishes containing 3ml
of LBN. Samples were incubated anaerobically at 37◦C for 24 h.
Planktonic cells were removed by washing the wells twice with
PBS and fresh L-broth-50mM potassium phosphate, pH 6.5
containing 15mM KNO3 (control) or 15mM KNO3 plus 15mM
NaNO2. Cultures were incubated in an anaerobic chamber for
2 days at 37◦C. After removing the planktonic cells by two
washes with PBS, biofilm bacteria were exposed to a cell viability
stain (BacLight, Invitrogen) composed of SYTO 9 and propidium
iodine. Biofilm images were obtained using an LSM 710 confocal
microscope (Zeiss, Heidelberg, Germany). The excitation and
emission wavelengths for green fluorescence were 488 and
500 nm, while those for red fluorescence were 490 and 635 nm,
respectively. All biofilm experiments were repeated indepently at
least 3 times. The live/dead ratios of the biofilms were calculated
using the ImageJ software. The percentage of dead/live ratio was
normalized after comparisons between treated (NO−3 plus NO
−
2 )
and control (NO−3 alone).
Antibiotic MIC Determinations
Minimum inhibitory concentration (MIC) testing was performed
using the Etest system (bioMerieux, Marcy-l-Etoile, France)
following manufacturer guidelines. Testing was performed
using 150mm cation adjusted Mueller Hinton agar plates (BD
Diagnostics, Sparks, MD) incubated at 35◦C for 18–24 h in
ambient air.
Mouse Acute Pneumonia Infection Model
Six-week old male BALB/c mice (19–21 g) were purchased
from Taconics (Cambridge City, IN). All animals were housed
in positively ventilated microisolator cages with automatic
recirculating water located in a roomwith laminar, high efficiency
particulate-filtered air. The animals received autoclaved food,
water, and bedding. Mice were handled in accordance with
approved protocols through the Institutional Animal Care
and Use Committee at the University of Illinois at Urbana-
Champaign. Mice were infected intranasally with 1 × 106 CFU
of strain PAO1, the PA4455 mutant, or the complemented strain
(pUCP-PA4455; Zhang et al., 2005; Hao et al., 2011). After 20 h,
mice were euthanized and lungs were harvested, homogenized,
serially diluted and plated on PIA with or without 400µg/ml
carbenicillin for determination of bacterial load.
Transmission Electron Microscopy (TEM)
of Bacterial Samples
Overnight cultures were diluted 1:100 in fresh L-broth and
incubated at 37◦C with shaking until late log phase. Culture
samples were removed and adjusted to an OD600 of 1.0 and the
bacteria clarified by centrifugation at 2600 RPM (∼600 ×g) for
5min. The cells were then prepared for TEM using a protocol
described by Kim et al. (2007) with slight modifications. The cells
were washed three times in 0.1M sodium cacodylate, then stained
and fixed with a 1:1 mixture of 1% osmium tetraoxide with
7.5mg/ml of potassium ferricyanide and a 5% glutaraldehyde
solution. After 1 h, the cells were washed again with 0.1M sodium
cacodylate and subjected to a graded series of ethanol (25–100%),
each for 15min, followed by a 100% acetone wash for another
15min. The cells were infiltrated and embedded in LX-112 Resin
(Ladd Research Industries). The resin was sectioned using a Leica
EM UC 7 ultramicrotome to 100 nm. Images were taken on a
Hitachi H 750 transmission electron microscope operating at
100 kV.
RESULTS
Identification of PA4455, Encoding a
Putative ABC Transporter Permease: A
Gene Critical for Resistance to A-NO−2
In this study, we used a Tn mutagenesis approach to
identify mutants that demonstrated increased sensitivity to
A-NO−2 relative to wild-type bacteria. Colonies that were
patched from PIA-Gm plates onto PIA-Gm/A-NO−2 plates
that showed little or no growth were screened for A-NO−2
sensitivity followed by sequencing of the Tn-interrupted gene.
The most sensitive mutant whose gene product was not
deemed cytoplasmic in location based upon the membrane
topology program SOSUI (http://harrier.nagahama-i-bio.ac.jp/
sosui/sosui_submit.html), and hence a potential viable drug
target, was that involving a Tn insertion within the PA4455
gene. The PA4455 gene encodes a putative ABC transporter
permease that has 6 predicted membrane-spanning domains
(Figures 1A,B) within the cytoplasmic membrane (Class 3).
However, experimental evidence also shows that the 28.4-
kDa protein encoded by PA4455 can also be localized within
membrane vesicles (class I) based upon MALDI-TOF mass
spectrometric analysis (www.pseudomonas.com; Choi et al.,
2011). This predicted topology was also supported by other
cellular localization programs including TOPPRED (https://
bioweb.pasteur.fr/packages/pack@toppred@1.10) and PSORTb
V. 3.0 (http://www.psort.org/psortb/; data not shown).
The initial transponson mutant (designated P33) had a
Tn insertion located 436 bp from the 5′ end of the PA4455
ORF with Gm resistance determinant (aaC1) transcribed in
the same orientation as PA4455 (Figure 2). We believed it
was unlikely that the Tn insertion would exert any polar
effects on downstream genes that included PA4454, PA4453,
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FIGURE 1 | Software predictions of the transmembrane domains of PA4455. (A) Helical wheel diagram of predicted transmembrane segments of PA4455.
Hydrophobic residues, black; Polar residues, blue; Charged residues, Bold blue (+) and Bold red (−). (B) Predicted membrane topology of PA4455 within the
cytoplasmic membrane. Primary and secondary membrane spanning helices are indicated by dark or light green color, respectively.
PA4455 PA4456 PA4454 PA4453 PA4452 
aaC1 
WT 
P33/PAO1 PA4455::GmR 
yrbE yrbD yrbF 
4989304 4985843 
Bases (primary annotation) 
FIGURE 2 | Schematic diagram of the strategy to generate a deletion mutant of the PA4455 gene. The genomic region of PA spanning base pairs
4989304–4985843 are shown at the top of the figure. The designated genes yrbF, yrbE, and yrbD are based upon homology to Bacillus subtilis genes as analyzed by
www.pseudomonas.com. The second construct, PAO1 PA4455::GmR, harbors a gentamicin resistance cassette (GmR) interrupting the PA4455 gene.
and PA4452, each of which encode conserved hypothetical
proteins, respectively. We next constructed a PA4455 knockout
mutant using the standard strategy of insertional disruption
with a gentamycin cassette (GmR) followed by allelic exchange
(Figure 2). The resultant mutant strain, PAO1 PA4455::GmR,
exhibited the same level of sensitivity to A-NO−2 as the Tn
mutant P33. We did not believe this mutant would have any
polar effects on nearby genes. Although modest increases in
mRNA levels of up- and down-stream genes were observed in
the mutants, we do not believe this is causing the phenotypic
effects observed in this work because of the complementation
of each phenotype by provision of PA4455 in trans. This was
confirmed by transcriptional analysis of the aforementioned
genes using qPCR, comparing the gene expression to a previously
used housekeeping gene acpP (Supplementary Figure 1) from
both aerobically and anaerobically grown samples (Lenz et al.,
2008). Both mutant strains displayed no growth defect in regular
LB or LBN media compared to the wild-type strain PAO1 (data
not shown). Thus, we used PAO1-PA4455::GmR (herein PA4455
mutant) for the remainder of our studies.
Sensitivity of Planktonic PA4455 Mutant
Bacteria to A-NO−2 under Aerobic and
Anaerobic Conditions
Using a simple serial dilution plating assay, we monitored the
sensitivity of the PA4455 mutant bacteria relative to wild-type
bacteria and complemented strains. Serially diluted bacterial
suspensions were spotted onto LBN plates ± 17mM A-NO−2
(aerobic) or 7.5mM A-NO−2 (anaerobic), respectively, based on
preliminary experiments which determined these concentrations
as a minimum to discern a noticeable effect on viability (data
not shown). The results in Figure 3B (compared to Figure 3A
controls) demonstrates that the PA4455 mutant is dramatically
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FIGURE 3 | Sensitivity of planktonic PA4455 mutant bacteria to A-NO−
2
under aerobic conditions. Serial dilutions (x-axis) of aerobically grown
stationary phase bacteria were spotted onto LBN plates (A, control) or (B)
LBN plates ± 17mM A-NO−2 and incubated aerobically for 48 h at 37
◦C. The
lids were removed and the plates were scanned by an HP Scanjet 7400c
using Adobe Photoshop and edited for visual clarity using
Powerpoint:Mac2011 software.
A B
FIGURE 4 | Sensitivity of planktonic PA4455 mutant bacteria to A-NO−
2
under anaerobic conditions. Serial dilutions (x-axis) of aerobically grown
stationary phase bacteria were spotted onto LBN plates (A, control) or (B) ±
7.5mM A-NO−2 and incubated anaerobically for 48–72 h at 37
◦C. The lids
were removed and the plates were scanned by an HP Scanjet 7400c using
Adobe Photoshop and edited for visual clarity using Powerpoint:Mac2011
software.
more sensitive to A-NO−2 than wild-type bacteria under both
aerobic and, most dramatically, under anaerobic conditions
(Figure 4B compared to Figure 4A). Complementation was
achieved in trans on a multi-copy plasmid, pUCP-PA4455. For
comparison, we also used mucoid mucA22 (previously shown
to be sensitive to A-NO−2 Yoon et al., 2006) and a mucA22
PA4455 double mutant. Interestingly, both mucA22 and the
double mutant bacteria were indistinguishable in anaerobic A-
NO−2 sensitivity relative to the PA4455mutant alone (Figure 4B)
yet the double mutant was ∼10-fold more sensitive to A-NO−2
under aerobic conditions (Figure 3B).
Sensitivity of Biofilm PA4455 Mutant
Bacteria to A-NO−2 under Anaerobic
Conditions
Since A-NO−2 sensitivity in PA is more pronounced under
anaerobic conditions (Yoon et al., 2006), we next elected to
grow bacteria as a biofilm under anaerobic conditions via NO−3
respiration and assess the relative sensitivity of wild-type and
the PA4455 mutant to A-NO−2 . We have previously shown that
anaerobic conditions favor more robust biofilm formation than
under aerobic conditions (Yoon et al., 2002). In this experiment,
we observed that the PA4455 mutant is highly sensitive to A-
NO−2 when compared to wild-type and complemented bacteria,
as shown by a shift in the live/dead ratio of the biofilm bacteria
(Figures 5A,B).
Denitrification Pathway Transcriptional
Activities are Increased under Anaerobic
Conditions in the PA4455 Mutant Relative
to Wild-Type Bacteria
To evaluate whether transcription of genes involved in anaerobic
respiration were potentially altered in the PA4455mutant relative
to wild-type bacteria that may alter the overall sensitivity to A-
NO−2 of the PA4455 mutant observed in Figures 3B, 4B, we
assessed the aerobic and anaerobic transcriptional activity of
the nirS (encoding nitrite reductase), nirQ (encoding the NirQ
anaerobic regulator), norC (encoding the NorC component of
NO reductase) and narK (encoding the NarK eﬄux pump)
promoters using classical lacZ fusion analyses. PA strains PAO1
(wild-type) and its isogenic PA4455 mutant were transformed
with pQF50 (vector control), pHA531 (nirS::lacZ), pHA532
(nirQ::lacZ), pHA533 (norC::lacZ), or pQF-narK (narK::lacZ),
respectively. Next, β-galactosidase activity was measured in cells
grown in LBN broth under aerobic and anaerobic conditions
overnight. In support of our hypothesis, the PA4455 mutant
exhibited a clear upregulation of several of the aforementioned
genes anaerobically, indicating that NO−3 may more readily pass
through the membrane of the mutant and trigger transcriptional
activation of these genes. This presumably could apply to NO−2
as well, explaining the increased sensitivity to it. Under aerobic
conditions, transcriptional activity was noticeably lower in strain
PA4455 when compared to wild-type levels, which, although
unexpected, indicate that perhaps the cell has developed an
altered preference for the available nitrogen sources (Figure 6A).
Anaerobically, when the denitrification pathway is active, gene
activation levels increased dramatically (often ∼2-fold higher)
in the PA4455 mutant relative to the wild-type in nirS, and
norC transcription, but interestingly not in narK transcription
(Figure 6B). Unexpectedly, nirQ was lower anaerobically in
PA4455 than in PAO1, although both levels were also lower than
their respective controls.
Response of the PA4455 Mutant to
Membrane Stressors: Sensitivity to the
Chelator EDTA but Not SDS
SDS has been shown more than 40 years ago to cause significant
bacterial membrane damage with subsequent release of DNA,
RNA and protein (Woldringh and van Iterson, 1972). It has
also long been known that the chelator EDTA has pleotropic
effects on the lipopolysaccharide of PA (Champlin et al., 2005;
Alakomi et al., 2006). Thus, we postulated that the PA4455
mutant, because of an absence of the 6 membrane-spanning
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FIGURE 5 | Sensitivity of biofilm PA4455 mutant bacteria to A-NO−
2
under anaerobic conditions. (A) Biofilms were grown anaerobically in LBN for 24 h in
glass bottomed culture dishes. Spent medium was gently aspirated and replaced with LBN-50mM potassium phosphate, pH 6.5, containing 15mM NaNO2.
Cultures were incubated in an anaerobic chamber for 2 days at 37◦C. Biofilms were then stained a cell viability stain (BacLight, InVitrogen) composed of SYTO 9 and
propidium iodine. Biofilm images were obtained using an LSM 510 confocal microscope (Carl Zeiss, Inc., Germany). The excitation and emission wavelengths for
green fluorescence were 488 nm and 500 nm, while those for red fluorescence were 490 nm and 635 nm, respectively. All biofilm experiments were repeated at least 3
times. (B) The live/dead ratios of the biofilms were calculated using ImageJ image processing program.
A B
FIGURE 6 | Transcriptional activity of the nirS, nirQ, norC, and narK promoters probed by lacZ fusion analysis under aerobic (A) versus anaerobic (B)
conditions. PA PAO1 (wild-type) and its isogenic 1PA4455::GmR mutant were transformed with pQF50 (vector control), pHA531 (nirS::lacZ), pHA532 (nirQ::lacZ),
pHA533 (norC::lacZ), or pQF-narK (narK::lacZ), respectively. β-galactosidase activity was measured in cells grown in LBN broth under aerobic and anaerobic
conditions. Reported values are the averages of 4 independent experiments. (*) designates >95% confidence.
protein, PA4455, may be unusually sensitive to not only A-
NO−2 (Figures 3–5) but also to EDTA and SDS. In addition,
its homolog in E. coli demonstrated sensitivity to EDTA and
several other membrane stressors, suggesting that perhaps this
phenomenon would exist in PA as well (Malinverni and Silhavy,
2009). The results displayed in Figure 7B clearly indicate that the
wild-type and all tested mutant and complemented bacteria were
not sensitive to 0.5% SDS relative to control bacteria (Figure 7A).
In contrast, treatment of bacteria with 1mM EDTA clearly killed
the vast majority of the PA4455 mutant bacteria (Figure 7C).
We also tested alginate-overproducing strains PAmucA22, which
expresses a truncated 15.8-kDa MucA protein, and a mucA
deletion mutant (1mucA). Surprisingly, only the 1mucA strain
was sensitive to 1mM EDTA.
PPA4455-lacZ Reporter Activity is Affected
by Treatment with EDTA but Not A-NO−2 ,
SDS or Polymyxin B
We next elected to assess whether A-NO−2 , EDTA, SDS, or
polymyxin B (PMB) affected transcription of the PA4455
gene. Wild-type bacteria were transformed with a mini-
CTX-pPA4455-lacZ reporter plasmid for attB integration. For
pPA4455, it was found that reporter activity was increased
in response only to EDTA, but interestingly not to any of
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FIGURE 7 | Sensitivity of various mutant strains to the membrane permeabilizing agents SDS and EDTA. Serial dilutions (x-axis) of aerobically grown
stationary phase bacteria were spotted onto LBN plates (A), control, (B) 0.5% SDS, or (C) 1mM EDTA and incubated aerobically for 48 h at 37◦C. The lids were
removed and the plates were scanned by an HP Scanjet 7400c using Adobe Photoshop and edited for visual clarity using Powerpoint:Mac2011 software.
A
B
FIGURE 8 | Transcriptional activity of PA4455 in response to different
stressors under (A) aerobic or (B) anaerobic conditions. PAO1
attB::pPA4455-lacZ was used to determine the activation of PA4455 under
membrane stress. Cells were incubated aerobically (A) or anaerobically (B)
overnight with the different stresses (10mM NaNO2, 0.5mM EDTA, 0.5%
SDS, or 2µg/ml of polymyxin B). Then, the samples were diluted to an
O.D.600 of approximately 0.4 and β-galactosidase activity was measured.
Reported values are the average of 3 independent experiments. (*)
designates >90% confidence.
the other agents (Figure 8). This suggests that the protein
is at least partially responsible for structural stability (or the
response to repair) of the cell membrane. The most dramatic
response was due to EDTA, which caused a ∼1.6-fold increase
in reporter activity. Statistical significance only existed for
EDTA aerobically (p < 0.05 against all groups except the
combination treatment) but not anaerobically using a one-way
ANOVA.
B-band but Not A-band
Lipopolysaccharide (LPS) O-antigen
Mutants are Defective in Anaerobic Growth
and are More Susceptible to the Effects of
A-NO−2 and EDTA
We next postulated that one cellular structure that might be
affected by the combined microbicidal activities of A-NO−2
and/or EDTA would be the LPS of PA. EDTA is notorious for
damaging the outer membrane of Gram-negative bacteria such
as PA (Alakomi et al., 2006). With such damage, LPS molecules
with associated proteins have been shown to be released into
the medium (Matsushita et al., 1978), further compromising
the outer membrane function that can lead to cell death. One
function of LPS, the major component of the outer membrane,
is to help protect the membrane from potential damaging agents.
We postulated that an absence of the putative ABC transporter
permease, PA4455, could perturb the inner membrane of PA, that
may, in turn, affect the overall behavior of the outer membrane
and associated LPS molecules. Given that lipid A mutants cannot
be constructed because such mutations are lethal, we used O-
antigen (A-band- and/or B-band-deficient) mutants of the LPS
layer and assessed the antimicrobial activity of A-NO−2 ± EDTA
in comparison to sensitivity of wild-type bacteria. These mutants
included rmlC (A−B−, encoding a C3′ and C5′ carbohydrate
epimerase Rahim et al., 2000; Dong et al., 2007), rmd (A−B+,
that converts GDP-D-mannose to GDP-D-rhamnose (Rocchetta
et al., 1998b), and wbpM (A+B−; Creuzenet and Lam, 2001),
respectively (Supplementary Figure 2, Figure 9). Our results
revealed that an rmdmutant was the least affected when growing
anaerobically or in the presence of either 15mM NO−2 ± 1mM
EDTA (Figure 9). However, consistent with a previous report
(Murphy et al., 2014), the rmdmutant grew more efficiently than
wild-type bacteria under both aerobic and anaerobic conditions.
In contrast, mutants that do not produce B-band LPS, wbpM,
and most pronounced in rmlC, either grow extremely poorly
or do not grow under anaerobic conditions. The rmlC mutant,
however, was the most susceptible when grown in the presence of
either 15mM NO−2 or 1mM EDTA. These observations suggest
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FIGURE 9 | Susceptibility of planktonic LPS mutants vs. PA4455 to A-NO−
2
and EDTA under aerobic vs. anaerobic conditions. PAO1 (A+, B+), wbpM
(A+, B−), rmd (A−, B+), and rmlC (A−, B−) were grown aerobically overnight at 37◦C in LB, and then sub-cultured into LBN pH 6.5 media at a 1:100 ratio. Serial
dilutions were spotted on LBN plates containing control 50mM potassium phosphate, pH 6.5, ± 10mM NaNO2, ± 1mM EDTA and incubated aerobically (A, 24–48
h) or anaerobically (B, 72 h) at 37◦C. The hatched white boxes designate where noticeable growth occurred on the plates.
that B-band LPS is required to shield the PA outer membrane
from the bactericidal effects of EDTA and A-NO2, yet also is
essential for optimal anaerobic growth and survival (Figure 9).
Antibiotic MIC Determinations
Since the PA4455 protein is predicted to facilitate transport of
small molecules into PA, we next assessed whether the PA4455
mutant possessed altered minimal inhibitory concentration
(MIC) values to a large panel of antibiotics. The PA4455
mutant was 4-, 6-, 8-, and 8-fold more sensitive than wild-
type bacteria to chloramphenicol, colistin, tigecycline, and
doxycycline, respectively (Table 2). In contrast, the mutant strain
was 4- and 64-fold more resistant to ticarcillin/clavulanic acid
and gentamicin (serving as the positive resistance control),
respectively.
Attenuated Virulence of a PA4455 Mutant
Relative to Wild-Type Bacteria
Finally, we assessed the role of PA4455 in animal virulence
using an established acute murine lung infection model of PA
infection. Mice were infected intranasally as we have previously
described (Lau et al., 2005) using 1 × 106 CFU of the wild-type,
the PA4455mutant, and PA4455-pUCP-PA4455 bacteria and the
lungs harvested and homogenized after 20 h. The PA4455mutant
was found to be ∼10-fold less virulent than wild-type bacteria
(Figure 10).
DISCUSSION
Microaerobic/Anaerobic Bacterial Biofilms
in CF Airway Disease
This study stemmed from two seminal works in 2002
demonstrating that PA grows as microaerobic or anaerobic
biofilms in thick mucus plugs lining the CF airway lumen
(Worlitzsch et al., 2002; Yoon et al., 2002) and likely
that of the COPD airway mucus (Hassett et al., 2014).
Although initially the aforementioned studies were met with
some skepticism (Alvarez-Ortega and Harwood, 2007), there
FIGURE 10 | Virulence of the PA4455 mutant is reduced relative to
wild-type bacteria in a mouse acute respiratory model. BALB/c mice (6
per bacterial strain) were infected with 1× 107 CFU of the PA4455 mutant,
PAO1, or the complemented mutant intratracheally. After 20 h of infection, the
lungs were harvested and homogenized, and the resulting serially diluted
suspensions were assessed for CFU. (*) designates × > 95% confidence
interval.
have been 205 citations in PUBMEDwhen the words “anaerobic”
and “cystic fibrosis” were searched prior to the submission of
this work for publication (February 5, 2016). The definitive
supporting work was provided by a research group (Tunney
et al., 2008) who reported the isolation of obligate anaerobes
in CF sputum. Furthermore, PA infected sputum samples
produce a gaseous product of anaerobic respiration nitrous oxide
(N2O), further evidence that PA is undergoing this process
in the CF airway soccerball-shaped biofilms (Kolpen et al.,
2014).
A-NO−2 : Relevant Genes Involved in
Resistance and Translational Potential
Relatedly, one hallmark of both chronic CF and COPD is
the emergence of the mucoid, mucA22 form of PA that
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TABLE 2 | MIC’s in µg/ml for select antimicrobial agents representing
different classes of antibiotics.
Antimicrobial PAO1 PA4455 PA4455/pUCP-PA4455 Fold resistance (R)
or susceptible (S)
Cefoxitin >256 >256 >256 No difference
Ceftazadime 2 2 2 No difference
Cefepime 1.5 1.5 1.5 No difference
Ticarcillin/
Clavulanic Acid
32 128 96 4R
Pipercillin/
Tazobactam
3 4 4 No difference
Imipenem 2 2 2 No difference
Meropenem 1 1.5 1 No difference
Aztreonam 2 3 4 No difference
Amikacin 4 4 4 No difference
Gentamicin 3 192 128 64R
Ciprofloxacin 0.19 0.064 0.19
Doxycycline 32 4 16 8S
Tigecycline 24 3 16 8S
Colistin 3 0.5 2 6S
Chloramphenicol 24 6 16 4S
are highly resistant to conventional antibiotics used to treat
the aforementioned diseases. Surprisingly, Hassett (1996) has
previously shown that anaerobic conditions promote mucoid
stability, while static aerobic growth allows for mucoid-to-
nonmucoid conversion. In 2006, we demonstrated that mucoid
mucA22 bacteria are surprisingly and uniquely susceptible to
the NO-donor, A-NO−2 at pH 6.5, the approximate pH of the
CF airway mucus (Coakley et al., 2003; Yoon et al., 2006).
Specifically, we demonstrated that A-NO−2 killed mucoid PA in
(a) anaerobic biofilms; (b) sterile ultrasupernatants of airway
secretions derived from explanted CF lungs; and (c) a mouse
model of PA lung infection in a pH-dependent fashion, with no
organisms remaining after daily exposure to A-NO−2 for 16 days
(Yoon et al., 2006). The A-NO−2 translational approach for the
treatment of mucoid PA is also effective at killing methicillin-
resistant S. aureus (MRSA) and Burkholderia cepacia, that, with
PA, represent two other major CF pathogens (Major et al.,
2010). Finally, Yoon et al. (2006) clearly showed that A-NO−2
at concentrations up to 300mM did not elicit LDH release
from human CF airway epithelia or alter transepithelial short
circuit current, transepithelial water flux, or IL-8 release. More
recent comparable results to the aforementioned were also found
independently by another research group (Zemke et al., 2014).
The seemingly paltry level of NOderived fromNO−2 reduction
also was found to trigger dispersion of mature, preformed
biofilms (Barraud et al., 2006), likely an event that threatens
bacterial viability within biofilms. Bacteria such as PA possess
an obvious protective mechanism against NO, the respiratory
NO reductase (NOR). Thus, without NOR, the bacteria grow
abysmally slowly under anaerobic conditions due to high
endogenous NO production (∼16µM; Yoon et al., 2007). Similar
to the NO detoxifying properties of NOR, much to our surprise,
we also recently discovered that the major catalase of PA, KatA,
is produced at higher levels during anaerobic growth and is
essential for optimal protection against endogenous NO and
A-NO−2 treatment in both planktonic and biofilm culture due
to its ability to “buffer” NO (Su et al., 2014). Many studies
in both Gram-positive and Gram-negative bacteria have clearly
shown that many ABC transporters are involved in resistance
to a variety of antibiotics (Reilman et al., 2014; Pletzer et al.,
2015). In one particular study, overexpression in a highly
antibiotic-sensitive strain of E. coli of SmrA, a novel multi-
drug eﬄux pump from Stenotrophomonas maltophilia, allowed
for resistance to fluoroquinolones, tetracycline, doxorubicin
and multiple dyes (Al-Hamad et al., 2009). Our work shows
that PA4455 is essential for optimal resistance to doxycycline
(alters membrane permeability), tigecycline (alters membrane
permeability), colistin (punctures cytoplasmic membrane), and
chloramphenicol (transport via facilitated diffusion; Table 2). A
study performed with E. coli revealed that an ABC transporter
was essential for proper transport of lipopolysaccharide to
the outer membrane (Sherman et al., 2013). Our results
suggest that one of the functions of PA4455 is to stabilize
the cytoplasmic membrane as well as to control the rate of
A-NO−2 transport into PA during anaerobic growth. As observed
with the activation of the promoter-lacZ fusion, the PA4455
mutant consistently expressed higher levels of some of the
genes associated with the denitrification (anaerobic respiratory)
pathway. While this in itself might suggest that the membrane
would have significant alterations that could allow for greater
access to nitrate or nitrite, none were immediately apparent by
TEM (Supplementary Figure 3). Were such alterations to be
present, they may be subtle and not easily detectable as clear
physical membrane deformities, but rather structural changes or
reorganizations due to a less stabilized membrane.
EDTA is Synergistic with A-NO−2 in the
Killing of PA
EDTA has been shown to have markedly detrimental effects
on bacterial outer membranes, ultimately causing leakage of
LPS and increased permeabilization to biocides (Alakomi et al.,
2006). In 1980, Wood et al. (1980) demonstrated the synergistic
effect of EDTA and several antibiotics including penicillin G,
ampicillin, tetracycline, gentamicin, and carbenicillin on mucoid
and nonmucoid PA. EDTA has also been shown to inhibit
PA biofilm formation, especially under anaerobic conditions
(O’May et al., 2009). Supportively, a recent study has shown
that A-NO−2 inhibited 99% of PA biofilm formation on primary
CF epithelial cell (Zemke et al., 2014). The same group also
showed that A-NO−2 is synergistic at killing PA biofilms with
the membrane disrupting agent colistimethate (polymyxin E)
but inhibits the microbicidal activity of aminoglycosides (Zemke
et al., 2015). In CF patients, Brown et al. (1985) showed that
NO−2 at doses as high as 250mM were non-toxic. Based on the
phenotypic evidence found associated with our PA4455 mutant,
we believe that the gene product is important for the overall
membrane stability associated with PA. It may be possible that
without PA4455, the membrane integrity is perturbed, thereby
allowing the entrance of small molecules such as NO−2 that are
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normally not permitted full entry into the cell. This could explain
the elevated transcriptional regulation of genes associated with
anaerobic respiration in the PA4455mutant.
B-band LPS is Necessary for Anaerobic
Growth and Optimal Resistance to A-NO−2
and EDTA
It has previously been shown that B-band LPS production
is significantly reduced during anaerobic growth, while it is
dramatically overproduced under oxidative stress conditions
(e.g., exposure to H2O2; Sabra et al., 2003). The highly negatively
charged form of B-band O antigen, known as B-band LPS,
is necessary for formation of membrane vesicles inducible by
oxidative stress in the form of H2O2 (Macdonald and Kuehn,
2013). Our results, unexpectedly, suggest that B-band LPS is
critical not only for anaerobic growth of PA, but also for optimal
resistance to EDTA and A-NO−2 . The molecular basis underlying
this phenomenon is currently under study. In E. coli, a mutant
lacking a PA4455 ABC transporter permease homolog, MlaE,
was found to be exquisitely susceptible to EDTA/SDS and this
was thought be to due to increased cellular permeabilization
(Malinverni and Silhavy, 2009). One unique feature of the
A-NO−2 and/or EDTA sensitivity of the various mutant strains
used in this study was the consistent and very dramatic sensitivity
of B-band LPS mutants.
SUMMARY
In summary, the discovery of PA4455 as being a critical
component in resistance to both A-NO−2 and EDTA was
unexpected, yet potentially intriguing for translational purposes.
Given the promising results of this study, we believe that
the combination of A-NO−2 and EDTA represents a novel
combinatorial, non-toxic treatment that could potentially achieve
the translational goal of eradicating nonmucoid and mucoid
PA (and potentially other organisms) in the CF and COPD
airways.
AUTHOR CONTRIBUTIONS
Substantial contributions to the conception or design of the work;
or the acquisition, analysis, or interpretation of data for the work
(CM, SS, WP, GL, TB, KC, AP, SK, JM, JL, DM, DH); drafting
the work or revising it critically for important intellectual content
(CM, SS, WP, GL, TB, KC, AP, SK, JM, JL, DM, DH); final
approval of the version to be published (CM, SS, WP, GL, TB,
KC, AP, SK, JM, JL, DM, DH); Agreement to be accountable for
all aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved (CM, SS, WP, GL, TB, KC, AP, SK, JM,
JL, DM, DH).
FUNDING
This work was supported primarily by a Merit Review Grant
from the Department of Veteran’s Affairs, Cincinnati VA
Hospital (Cincinnati, OH). Additional support was from ARCH
Biopartners, Inc. (Toronto, Canada), Cystic Fibrosis Research,
Inc. (Mountain View, CA), Cure Finders, Inc. (Sevierville, TN),
Aires Pharma (San Diego, CA), and the Daniel Tyler Health and
Education Foundation (Fort Collins, CO).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2016.00291
Supplementary Figure 1 | qPCR results of wild-type and mutant bacteria.
RNA was extracted from late log phase growing organisms (PAO1, PA4455, and
pUCP-PA4455), then subjected to (A) PCR and (B,C) RT-PCR. Primers against
the middle regions of each shown gene were used. For RT-PCR, the reported
values are fold increases for each gene in each mutant bacteria over values for
PAO1 (2
11CT ). Initial 1CT measurements were calculated using each gene in the
PA4455 operon compared to the housekeeping gene, acpP. (B) Aerobic- and (C)
anaerobically grown organisms were both used for RT-PCR, and the averages of
each samples 2
11CT values are reported.
Supplementary Figure 2 | Diagrams of the LPS profile of wild-type, rmlC,
rmd, and wpbM mutant strains used in this study. Each sugar moiety is given
in a short table inserted within the figure. OSA, O-specific antigen; CSA, cell
surface antigen. Jagged black lines in the outer membrane (gray), lipid A. Adapted
from Lam et al. (2011).
Supplementary Figure 3 | TEM of wild-type, PA4455 mutant and PA4455
mutant complemented strains during anaerobic growth. Sections were
scanned for areas with predominant bacterial density, and images were taken at
100,000x magnification. (A) PAO1, (B) PA4455 mutant, (C) PA4455 mutant
complemented with pUCP-PA4455.
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